87341-53-5 Usage
Benzyl group attached to nitrogen
A benzyl group (C6H5CH2-) is a phenyl group (C6H5-) attached to a methylene group (-CH2-). In 1-Benzyl-5-oxopyrrolidine-2-carboxamide, this group is attached to the nitrogen atom in the pyrrolidine ring.
Building block in organic synthesis
This compound is used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals, meaning it is a starting material that can be further modified to create more complex molecules.
Potential biological activities
1-Benzyl-5-oxopyrrolidine-2-carboxamide has been studied for its possible therapeutic effects, such as its use as an anticonvulsant (to prevent or treat seizures) and a neuroprotective agent (to protect nerve cells from damage).
New drug development
The compound has shown promise in the development of new drugs for the treatment of various diseases, making it an important target for further research and investigation.
Check Digit Verification of cas no
The CAS Registry Mumber 87341-53-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,3,4 and 1 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 87341-53:
(7*8)+(6*7)+(5*3)+(4*4)+(3*1)+(2*5)+(1*3)=145
145 % 10 = 5
So 87341-53-5 is a valid CAS Registry Number.
87341-53-5Relevant articles and documents
Substituted 5-oxo-pyrrolidine derivative, and preparation method and applications thereof
-
, (2019/01/21)
The invention belongs to the technical field of medicine, relates to a substituted 5-oxo-pyrrolidine derivative disclosed in generation formula I, and a preparation method and applications thereof, and more specifically relates to applications of the substituted 5-oxo-pyrrolidine derivative in preparation of anti-cerebral ischemia medicines as a nerve protective agent, and a pharmaceutical composition taking the substituted 5-oxo-pyrrolidine derivative and a pharmaceutically acceptable salt of the substituted 5-oxo-pyrrolidine derivative as active components. The pharmaceutical composition contains the substituted 5-oxo-pyrrolidine derivative and a pharmaceutical excipient and/or a diluent of the substituted 5-oxo-pyrrolidine derivative. In the general formula I, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, Y, and n are defined in the patent specification and patent claims.
